West Pharmaceutical Services, Inc.
WSTFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
2,893
Cost of Revenue
1,891
Gross Profit
1,002
Gross Margin
34.6%
Operating Income
595
Operating Margin
20.6%
Net Income
493
Net Margin
17.0%
EPS (Basic)
$6.75
EPS (Diluted)
$6.69
EBITDA
744
EBITDA Margin
25.7%
2023
12/31/2023
Revenue
2,951
Cost of Revenue
1,818
Gross Profit
1,133
Gross Margin
38.4%
Operating Income
711
Operating Margin
24.1%
Net Income
593
Net Margin
20.1%
EPS (Basic)
$7.99
EPS (Diluted)
$7.88
EBITDA
844
EBITDA Margin
28.6%
2022
12/31/2022
Revenue
2,886
Cost of Revenue
1,747
Gross Profit
1,139
Gross Margin
39.5%
Operating Income
764
Operating Margin
26.5%
Net Income
586
Net Margin
20.3%
EPS (Basic)
$7.88
EPS (Diluted)
$7.73
EBITDA
808
EBITDA Margin
28.0%
2021
12/31/2021
Revenue
2,831
Cost of Revenue
1,657
Gross Profit
1,173
Gross Margin
41.5%
Operating Income
759
Operating Margin
26.8%
Net Income
662
Net Margin
23.4%
EPS (Basic)
$8.90
EPS (Diluted)
$8.67
EBITDA
880
EBITDA Margin
31.1%
2020
12/31/2020
Revenue
2,147
Cost of Revenue
1,379
Gross Profit
768
Gross Margin
35.8%
Operating Income
419
Operating Margin
19.5%
Net Income
346
Net Margin
16.1%
EPS (Basic)
$4.68
EPS (Diluted)
$4.57
EBITDA
519
EBITDA Margin
24.2%